Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

12 nov. 2015 07h00 HE | Source: Albireo Limited

Albireo to Present A4250 Clinical Data at the 2015 AASLD Annual Meeting

GOTHENBURG, Sweden and London, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Albireo Limited, a clinical-stage biopharmaceutical company developing through its operating subsidiary novel bile acid modulators to...
10 nov. 2015 07h00 HE | Source: Albireo Limited

Albireo Announces the Initiation in Japan of a Phase 3 Clinical Trial of Elobixibat in Chronic Constipation by Ajinomoto Pharmaceuticals

GOTHENBURG, Sweden and LONDON, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Albireo Limited, a clinical-stage biopharmaceutical company developing through its operating subsidiary novel bile acid modulators to...
23 sept. 2015 07h30 HE | Source: Albireo Limited

Albireo Appoints Ron Cooper, Former President of Europe at Bristol-Myers Squibb, as Chief Executive Officer

BOSTON, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Albireo Limited, a privately held company focused through its operating subsidiary on the development of bile acid modulators to treat orphan pediatric and...